These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20455854)

  • 21. [Cellular signaling in response to TGFbeta: the paradox of a factor that blocks cell proliferation and enhances metastasis].
    Vignais ML
    Bull Cancer; 1999 Nov; 86(11):903-10. PubMed ID: 10586106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGFβ in T cell biology and tumor immunity: Angel or devil?
    Tu E; Chia PZ; Chen W
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):423-35. PubMed ID: 25156420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells.
    Zhong Z; Carroll KD; Policarpio D; Osborn C; Gregory M; Bassi R; Jimenez X; Prewett M; Liebisch G; Persaud K; Burtrum D; Wang S; Surguladze D; Ng S; Griffith H; Balderes P; Doody J; Schwartz JD; Youssoufian H; Rowinsky EK; Ludwig DL; Witte L; Zhu Z; Wu Y
    Clin Cancer Res; 2010 Feb; 16(4):1191-205. PubMed ID: 20145179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming growth factor beta (TGF-beta) and inflammation in cancer.
    Bierie B; Moses HL
    Cytokine Growth Factor Rev; 2010 Feb; 21(1):49-59. PubMed ID: 20018551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The TGFBeta pathway as a therapeutic target in cancer.
    Seoane J
    Clin Transl Oncol; 2008 Jan; 10(1):14-9. PubMed ID: 18208788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.
    Muraoka-Cook RS; Dumont N; Arteaga CL
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):937s-43s. PubMed ID: 15701890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing cancer vaccine efficacy via modulation of the tumor microenvironment.
    Disis ML
    Clin Cancer Res; 2009 Nov; 15(21):6476-8. PubMed ID: 19861446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of TGFβ signaling and its implications in anticancer treatments.
    Calone I; Souchelnytskyi S
    Exp Oncol; 2012; 34(1):9-16. PubMed ID: 22453142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.
    Joffroy CM; Buck MB; Stope MB; Popp SL; Pfizenmaier K; Knabbe C
    Cancer Res; 2010 Feb; 70(4):1314-22. PubMed ID: 20145137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting TGFβ signal transduction for cancer therapy.
    Liu S; Ren J; Ten Dijke P
    Signal Transduct Target Ther; 2021 Jan; 6(1):8. PubMed ID: 33414388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta in cancer and metastasis.
    Jakowlew SB
    Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-metastasis function of TGFbeta mediated by the Smad pathway.
    Kang Y
    J Cell Biochem; 2006 Aug; 98(6):1380-90. PubMed ID: 16598746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGFβ Signaling in the Tumor Microenvironment.
    Goulet CR; Pouliot F
    Adv Exp Med Biol; 2021; 1270():89-105. PubMed ID: 33123995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The microRNA networks of TGFβ signaling in cancer.
    Sivadas VP; Kannan S
    Tumour Biol; 2014 Apr; 35(4):2857-69. PubMed ID: 24323563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
    J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escaping from the TGFbeta anti-proliferative control.
    Seoane J
    Carcinogenesis; 2006 Nov; 27(11):2148-56. PubMed ID: 16698802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
    Bierie B; Moses HL
    Nat Rev Cancer; 2006 Jul; 6(7):506-20. PubMed ID: 16794634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of EMT by TGFβ in cancer.
    Heldin CH; Vanlandewijck M; Moustakas A
    FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The two faces of transforming growth factor beta in carcinogenesis.
    Roberts AB; Wakefield LM
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8621-3. PubMed ID: 12861075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.